|
WDR36 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.378600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.503600E-01 |
| Normal-vs-Stage2 |
9.455600E-01 |
| Normal-vs-Stage3 |
5.945000E-01 |
| Normal-vs-Stage4 |
1.233210E-01 |
| Stage1-vs-Stage2 |
8.492000E-01 |
| Stage1-vs-Stage3 |
7.289800E-01 |
| Stage1-vs-Stage4 |
1.100780E-01 |
| Stage2-vs-Stage3 |
7.038200E-01 |
| Stage2-vs-Stage4 |
2.659200E-01 |
| Stage3-vs-Stage4 |
3.041800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.736800E-01 |
| Normal-vs-AfricanAmerican |
1.304200E-02 |
| Normal-vs-Asian |
2.764200E-01 |
| Caucasian-vs-AfricanAmerican |
4.682900E-03 |
| Caucasian-vs-Asian |
2.437400E-01 |
| AfricanAmerican-vs-Asian |
1.055730E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.489800E-01 |
| Normal-vs-Female |
5.707400E-01 |
| Male-vs-Female |
9.908000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.188300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.215400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.017200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.507800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.657500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.206780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.015200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.472600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.254800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.663400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.126400E-01 |
| Normal-vs-Grade 2 |
6.854400E-01 |
| Normal-vs-Grade 3 |
2.567800E-01 |
| Normal-vs-Grade 4 |
3.798000E-02 |
| Grade 1-vs-Grade 2 |
7.153600E-01 |
| Grade 1-vs-Grade 3 |
7.568200E-01 |
| Grade 1-vs-Grade 4 |
3.310200E-01 |
| Grade 2-vs-Grade 3 |
5.338100E-02 |
| Grade 2-vs-Grade 4 |
4.682300E-03 |
| Grade 3-vs-Grade 4 |
1.321990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.620800E-01 |
| Normal-vs-ccB subtype |
4.430000E-01 |
| ccA subtype-vs-ccB subtype |
3.716000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.548800E-01 |
| Normal-vs-N1 |
5.044400E-01 |
| N0-vs-N1 |
6.315800E-01 |
|
|
